Evidence map›Paper›PMID 28350814›Full record

ArticlePloS one2017

Compensatory changes in CYP expression in three different toxicology mouse models: CAR-null, Cyp3a-null, and Cyp2b9/10/13-null mice.

Ramiya Kumar, Linda C Mota, Elizabeth J Litoff, John P Rooney, W Tyler Boswell, Elliott Courter, Charles M Henderson, Juan P Hernandez, J Christopher Corton, David D Moore and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
5.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Knockdown of theInternational journal of molecular sciences · 2022
    Article
  8. Assessing cytochrome P450 function using genetically engineered mouse models.Advances in pharmacology (San Diego, Calif.) · 2022
    Review
  9. Article
  10. Article
  11. Increased toxicity and retention of perflourooctane sulfonate (PFOS) in humanized CYP2B6-Transgenic mice compared to Cyp2b-null mice is relieved by a high-fat diet (HFD).Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association · 2021
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Chemical Activation of the Constitutive Androstane Receptor Leads to Activation of Oxidant-Induced Nrf2.Toxicological sciences : an official journal of the Society of Toxicology · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Ramiya KumarBiological Sciences, Clemson University, Clemson, SC, United States of America.
Linda C MotaEnvironmental Toxicology, Clemson University, Pendleton, SC, United States of America.
Elizabeth J LitoffBiological Sciences, Clemson University, Clemson, SC, United States of America.
John P RooneyNHEERL, US-EPA, Research Triangle Park, NC, United States of America.
W Tyler BoswellBiological Sciences, Clemson University, Clemson, SC, United States of America.
Elliott CourterBiological Sciences, Clemson University, Clemson, SC, United States of America.
Charles M HendersonBiological Sciences, Clemson University, Clemson, SC, United States of America.
Juan P HernandezMolecular and Cellular Biology, Baylor College of Medicine, Houston, TX, United States of America.
J Christopher CortonNHEERL, US-EPA, Research Triangle Park, NC, United States of America.
David D MooreMolecular and Cellular Biology, Baylor College of Medicine, Houston, TX, United States of America.
William S BaldwinBiological Sciences, Clemson University, Clemson, SC, United States of America.ORCID http://orcid.org/0000-0002-9491-3403
Clemson University · USBaylor College of Medicine · USEnvironmental Protection Agency · US

Funding

Metabolic Regulation by the Nuclear Receptor CARR01DK046546 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI MOORE, DAVID D · 1995 to 2014
$4.9M
The Role of Cyp2b in Toxicant Metabolism and SensitivityR15ES017321 · NIEHS · CLEMSON UNIVERSITY · PI BALDWIN, WILLIAM S · 2009 to 2020
$1.3M
NIDDK NIH HHS R01 DK046546NIEHS NIH HHS R15 ES017321
6 · The paper itself

Abstract

Targeted mutant models are common in mechanistic toxicology experiments investigating the absorption, metabolism, distribution, or elimination (ADME) of chemicals from individuals. Key models include those for xenosensing transcription factors and cytochrome P450s (CYP). Here we investigated changes in transcript levels, protein expression, and steroid hydroxylation of several xenobiotic detoxifying CYPs in constitutive androstane receptor (CAR)-null and two CYP-null mouse models that have subfamily members regulated by CAR; the Cyp3a-null and a newly described Cyp2b9/10/13-null mouse model. Compensatory changes in CYP expression that occur in these models may also occur in polymorphic humans, or may complicate interpretation of ADME studies performed using these models. The loss of CAR causes significant changes in several CYPs probably due to loss of CAR-mediated constitutive regulation of these CYPs. Expression and activity changes include significant repression of Cyp2a and Cyp2b members with corresponding drops in 6α- and 16β-testosterone hydroxylase activity. Further, the ratio of 6α-/15α-hydroxylase activity, a biomarker of sexual dimorphism in the liver, indicates masculinization of female CAR-null mice, suggesting a role for CAR in the regulation of sexually dimorphic liver CYP profiles. The loss of Cyp3a causes fewer changes than CAR. Nevertheless, there are compensatory changes including gender-specific increases in Cyp2a and Cyp2b. Cyp2a and Cyp2b were down-regulated in CAR-null mice, suggesting activation of CAR and potentially PXR following loss of the Cyp3a members. However, the loss of Cyp2b causes few changes in hepatic CYP transcript levels and almost no significant compensatory changes in protein expression or activity with the possible exception of 6α-hydroxylase activity. This lack of a compensatory response in the Cyp2b9/10/13-null mice is probably due to low CYP2B hepatic expression, especially in male mice. Overall, compensatory and regulatory CYP changes followed the order CAR-null > Cyp3a-null > Cyp2b-null mice.

Indexed as

AnimalsAryl Hydrocarbon HydroxylasesConstitutive Androstane ReceptorCRISPR-Cas SystemsCytochrome P-450 CYP3ACytochrome P-450 Enzyme SystemCytochrome P450 Family 2FemaleGene DeletionGene ExpressionMembrane ProteinsMiceMice, Inbred C57BLMice, KnockoutPharmacological and Toxicological PhenomenaReceptors, Cytoplasmic and NuclearAryl Hydrocarbon HydroxylasesConstitutive Androstane ReceptorCyp2b10 protein, mouseCyp2b9 protein, mouseCyp3a11 protein, mousecytochrome P-450 2B13, mouseCytochrome P-450 CYP3ACytochrome P-450 Enzyme SystemCytochrome P450 Family 2Membrane ProteinsReceptors, Cytoplasmic and NuclearSteroid Hydroxylases

Identifiers

PMID28350814
PMCPMC5370058
OpenAlexW2601629510

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.